Burtness B, Rosenberg AJ, Calderon B, Lim SM, et al. Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study. J Clin Oncol 2026;44:2271-2277.
PMID: 42218660